Post - Marketing Case Registration Study on the Safety and Efficacy of Adalimumab Solution for Injection in Chinese Pediatric Patients With Moderate - to - Severe Active Crohn's Disease

Clinical trial NCT07564505 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07564505
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Children Aged 6 Years and Above With Moderate - to - Severe Active Crohn's Disease

Start date: 2026-05-01
Primary completion: 2029-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.